Fig. 1
From: Accelerating the manufacturing of HIV Env protein vaccines for early phase clinical evaluation
Comparison of approximate timelines to Upstream CGMP Production of HIV Env proteins for Electroporation vs Stable Pool vs Stable Cell lines, delineating the time for Process Development (PD) activities in a non-GMP environment and CGMP activities.
